Weisman Howard J.
- SEC CIK
- 0001811802
No open-market purchases or sales filed in the past year.
Current role at each company
- PXMD Kuvatris Therapeutics, Inc.Chief Executive Officeras of Mar 14, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Weisman Howard J. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2024 (view filing)5:16 PM ET | Jan 29 | 2 days | Weisman Howard J.Chief Executive Officer | SSale | −372 | $0.47 | −$174.84 | −1.0%37.7K after | |
| Nov 29, 2023 (view filing) | Nov 27 | 2 days | Weisman Howard J.Chairman and CEO | SSale | −162 | $1.03 | −$166.86 | −0.4%38.0K after | 10b5-1 |
| Oct 30, 2023 (view filing)4:11 PM ET | Oct 27 | 3 days | Weisman Howard J.Chairman and CEO | SSale | −8.05K | $0.1894 | −$1.52K | −1.2%649.5K after | 10b5-1 |
| Aug 30, 2023 (view filing)4:09 PM ET | Aug 28-30 | 2 days | Weisman Howard J.Chairman and CEO | SSale | −44.1K | $0.4659 | −$20.6K | −6.3%657.6K after | 3 lots10b5-1 |
| Mar 9, 2023 (view filing) | Mar 8-9 | 1 day | Weisman Howard J.Chief Executive Officer | SSale | −35.9K | $1.46 | −$52.3K | −6.2%541.6K after | 2 lots |
| Mar 7, 2023 (view filing) | Mar 6-7 | 1 day | Weisman Howard J.Chief Executive Officer | SSale | −37.1K | $1.60 | −$59.4K | −6.0%577.5K after | 2 lots |
| Mar 3, 2023 (view filing) | Mar 2-3 | 1 day | Weisman Howard J.Chief Executive Officer | SSale | −27.0K | $1.92 | −$51.8K | −4.2%614.7K after | 2 lots |